💊 Popular Asthma Drug May Cause Serious Mental Health Issues in Children and Adults, FDA Data Reveals
Singulair, a widely-prescribed asthma drug, may cause serious mental health issues, according to data revealed last week by the FDA. The researchers found that the drug, also sold under the generic label montelukast, attaches to multiple brain receptors critical to psychiatric functioning.
The data support the thousands of patients and dozens of studies that have reported harmful psychiatric side effects, including depression, suicide, anxiety and aggression.
Originally manufactured by Merck, the drug is prescribed for year-round indoor allergies in patients 6 months and up, seasonal outdoor allergies in patients 2 years and up, and for preventing asthma in patients 1 year and older.
READ MORE ⬇️
https://childrenshealthdefense.org/defender/singulair-montelukast-asthma-mental-health-fda/?utm_source=telegram&utm_medium=social&utm_campaign=defender&utm_id=20241126
Singulair, a widely-prescribed asthma drug, may cause serious mental health issues, according to data revealed last week by the FDA. The researchers found that the drug, also sold under the generic label montelukast, attaches to multiple brain receptors critical to psychiatric functioning.
The data support the thousands of patients and dozens of studies that have reported harmful psychiatric side effects, including depression, suicide, anxiety and aggression.
Originally manufactured by Merck, the drug is prescribed for year-round indoor allergies in patients 6 months and up, seasonal outdoor allergies in patients 2 years and up, and for preventing asthma in patients 1 year and older.
READ MORE ⬇️
https://childrenshealthdefense.org/defender/singulair-montelukast-asthma-mental-health-fda/?utm_source=telegram&utm_medium=social&utm_campaign=defender&utm_id=20241126